Celerion Protocols for Safe Clinical Research. Learn More

Get your drug to market faster. Better. For patients around the world.

Our 40+ years of experience, innovative strategies, global capabilities, and expertise in early phase research make us faster than our competitors. That means you get key data sooner, enabling you to make earlier go/no-go decisions about your drug's development. It’s all in the name: Celerion is derived from the Latin celeritas (meaning swiftness and speed), which reflects our founding principle—that fast, reliable research is vital to a product's success. Our vision is to be the premier provider of early stage drug development solutions to you, achieved through experienced leadership, the passion of our employees and a commitment to excellence.

We’ve come a long way since our legacy company’s first clinical trial in 1969. Today, Celerion is one of the world's leading CROs in early phase research, working with pharmaceutical and biotechnology companies and around the globe. We are more than 1,000 full-time scientific and medical personnel with the skills to design, execute, and interpret complex clinical studies, while upholding the highest standard of ethics. Our facilities offer over 600 beds and are among the most extensive in the industry, and our clinical research professionals have extensive experience and expertise to help you transition through Proof of Concept and beyond across North America, Europe, and Asia. Using these resources, we help get your product into the world faster, so you can start making a difference in people’s lives.

Enter to win a GoPro Hero 8

Sub Topic

Sea of Tranquility star stuff harvesting star light rings of Uranus a still more glorious dawn awaits a billion trillion Drake Equation.

Sub Topic

Sea of Tranquility star stuff harvesting star light rings of Uranus a still more glorious dawn awaits a billion trillion Drake Equation.

Sub Topic

Sea of Tranquility star stuff harvesting star light rings of Uranus a still more glorious dawn awaits a billion trillion Drake Equation.

Fact Sheet


Celerion Overview

Learn More

White Paper


Back to Basics: pH-Dependent Drug Interactions with Acid Reducing Agents

Learn More

White Paper


Women’s Health: Maximizing Study Design of Combined Oral Contraceptives Drug Interaction Studies

Learn More

White Paper


Perpetrator or Victim: Evaluating Therapeutic Proteins in Drug-Drug Interaction Studies

Learn More

Fact Sheet


Celerion Bioanalytical Sciences

Learn More

Webinar


Designed for Success: Early Phase Study Design For Biotech

Learn More

Webinar


ADME 101: Lessons on Running a Successful Clinical Mass Balance Trial

Learn More

Fact Sheet


Making Virtual Trials a Reality

Learn More

Article


Celerion Announces Investment in ADME Suite of Services

Learn More